NorthWest Biotherapeutics Inc (NWBO)

[pqr]

biosec: Nice. Thanks. Sounds about right. Separately, it seems a stretch to think that TLD is being held for patent application outcomes in addition to the (presumed) article, etc. The desire for a contemporaneously-announced journal article “explains” to some of us why
management’s announcement back in I think September of 2020 didn’t happen. But nothing about the patent landscape at that time would seem to have contributed to that obvious change in strategy which has exposed management to do much shareholder criticism. It is IMO unlikely that management could have decided after the initial withholding to further delay TLD for patent developments bc that assumes the journal would cooperate which I think the subject experts would tell us would not happen. GLTA